Author Index

A

  • Abbas, Neven Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Abdel-Razik, Ahmed Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Ali, Sarah Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Attia, Attia Ahmed Screening of Occult Hepatitis B Virus Infection among Egyptian Blood Donors. [5.2, Issue 2, 2021, Pages 27-31]

E

  • Ehab, Ahmed Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Elbadrawy, Tasnim Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • El-gharabawy, Sahar Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Elhelaly, Rania Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Elmetwalli, Alaa Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Elmetwalli, Alaa Screening of Occult Hepatitis B Virus Infection among Egyptian Blood Donors. [5.2, Issue 2, 2021, Pages 27-31]

H

  • Habeeb, Maha R. Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Habeeb, Maha R Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Hosni, Khaled Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]

M

  • Mahmoud, Alaa N Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Menesy, Ayman Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Mohamed, Farag Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Mousa, Aya Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Mousa, Eman Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Mousa, Nasser Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]

S

  • Sabry, Mohammed Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Saed, Ahmed Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Selim, Mahmoud Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Sheta, Tarek Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Shiha, Gamal Misuse of anticoagulants in COVID-19 patient: A case of gastrointestinal bleeding [5.2, Issue 2, 2021, Pages 1-2]
  • Soliman, Reham Misuse of anticoagulants in COVID-19 patient: A case of gastrointestinal bleeding [5.2, Issue 2, 2021, Pages 1-2]

T

  • Taha, Ahmed Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]